π§ CPT Code 64645 β Chemodenervation of One Extremity; Each Additional Extremity, 5 or More Muscle(s)
Quick Reference
π Clinical Description
CPT 64645 is a β+β designated add-on code that reports the injection of a chemical neurolytic agent β most commonly botulinum toxin A or B β into five or more muscles of each additional extremity treated beyond the first in a single session. It is the higher-complexity counterpart to 64643, which captures additional extremities with only 1-4 muscles. Like all add-on codes, 64645 cannot be reported as a standalone code β it must appear on the same claim as a primary chemodenervation code (64644 or 64642) and does not carry an independent global period. Modifier -51 is never applied to 64645.
The clinical context for 64645 involves patients with diffuse or multi-limb spasticity who require extensive neuromuscular intervention across multiple extremities β with five or more distinct muscle injection targets in each additional limb beyond the primary. This is most commonly encountered in patients with spastic quadriplegia from cerebral palsy, high-level spinal cord injury, severe traumatic brain injury, or progressivemultiple sclerosis, where each affected extremity may have deeply entrenched flexor or extensor spasticity across multiple muscle groups simultaneously.
The add-on code for each additional extremity is selected based on the muscle count of that specific extremity, not the primary. This means a session can include a combination of 64645 and 64643 add-on units when different additional extremities have different muscle counts. The primary code (64642 or 64644) always represents the most extensively treated limb.
This add-on code may be reported in the following clinical contexts:
- Spastic quadriplegia β all four extremities treated with 5 or more muscles each; 64644 primary + 64645 Γ 3 for maximum four-limb coverage
- Bilateral lower limb spasticity with multi-muscle involvement β both lower extremities with 5+ muscle injection targets; 64644 + 64645 Γ 1
- Bilateral upper limb spasticity β both arms with extensive flexor synergy requiring 5+ muscles per side
- Mixed quad-limb sessions β some extremities with 5+ muscles (64645 add-on), some with 1-4 muscles (64643 add-on), in the same session
π¬ Add-On Code Logic & Reporting Rules
| Extremity Injected | # Muscles | Code to Report |
|---|---|---|
| 1st extremity (any limb) β most muscles | 1-4 | 64642 β primary code |
| 1st extremity (any limb) β most muscles | 5 or more | 64644 β primary code |
| Each additional extremity | 1-4 | 64643 β add-on |
| Each additional extremity | 5 or more | 64645 β add-on (this code) |
Clinical Pearl β Per-Extremity Independent Selection
The add-on code (64643 vs. 64645) is chosen independently for each additional extremity based on its own muscle count. In a four-extremity session where the primary limb has 7 muscles, the second limb has 5, the third has 3, and the fourth has 6, the claim would be:
- 64644 (primary, 7 muscles)
- 64645 (2nd limb, 5 muscles)
- 64643 (3rd limb, 3 muscles)
- 64645 (4th limb, 6 muscles)
Two units of 64645 and one unit of 64643 β each determined by its own limbβs count. The wRVU for this session: 1.77 + 1.65 + 1.22 + 1.65 = 6.29 total wRVU before drug reimbursement.
β Procedure Includes
- Needle placement into 5 or more named muscles of the additional target extremity, percutaneous
- Injection of botulinum toxin or other chemical neurolytic agent into each targeted muscle of the additional limb
- Needle repositioning within the same muscle for multi-site delivery (not counted as additional muscles)
- Post-injection assessment for that extremity
- Documentation of: all muscles injected by name, muscle count, laterality, injection technique, agent used, dose per muscle, and clinical rationale for the additional extremity treatment
β Separately Reportable (Not Included)
- 95874 β Needle EMG guidance for chemodenervation injection; per-extremity add-on β a separate unit of 95874 may be reported for each additional extremity where EMG guidance is used; do not report 95873 and 95874 together for the same session
- 76942 β Ultrasonic guidance for needle placement; list separately; confirm payer policy on units when guidance is used for multiple extremities in the same session
- J0585 β OnabotulinumtoxinA (Botox), per unit β total units administered across all extremities
- J0586 β AbobotulinumtoxinA (Dysport), per 5 units
- J0587 β RimabotulinumtoxinB (Myobloc), per 100 units
- J0588 β IncobotulinumtoxinA (Xeomin), per unit
β Excludes / Do Not Report Together
| Code | Description | Relationship to 64645 |
|---|---|---|
| Standalone billing | N/A | 64645 cannot be reported without 64644 or 64642 on the same claim β it will be denied as an orphaned add-on; if the primary code is denied, 64645 must also be adjusted off the claim |
| 64643 | Chemodenervation, each additional extremity; 1-4 muscle(s) | Mutually exclusive with 64645 for the same additional extremity β use 64643 when that specific additional limb has 1-4 muscles; do NOT report both add-ons for the same limb |
| 64644 | Chemodenervation, 1 extremity; 5 or more muscle(s) | 64645 is added in conjunction with 64644, not reported as a second unit of 64644; never bill 64644 twice for two extremities β the additional limb always uses the add-on |
| 64615 | Chemodenervation; facial, trigeminal, cervical spinal, and accessory nerve muscles | CPT parenthetical guidelines prohibit reporting 64615 alongside the extremity chemodenervation family |
Critical Add-On Code Alert β Orphaned Add-On Risk
64645 is a β+β designated add-on code and will be systematically denied if its parent code is absent from the claim. This is most dangerous in authorization-related denials: if 64644 is denied for a prior auth issue and 64645 remains on the claim, 64645 will also deny as an orphaned add-on. Billing teams must track these codes as a tightly linked set and adjust add-ons simultaneously whenever a primary code is retracted. There is no modifier that rescues an orphaned add-on β the primary must be present and payable.
π³ Code Tree β Destruction by Neurolytic Agent (Extremity Chemodenervation)
CPT 64600-64681 Surgery: Destruction by Neurolytic Agent
β
βββ 64612-64617 Chemodenervation β Head, Neck, Larynx
β βββ 64612 Chemodenervation; facial nerve muscle(s), unilateral
β βββ 64615 Chemodenervation; facial, trigeminal, cervical spinal, accessory nerves
β βββ 64616 Chemodenervation; neck muscle(s), excluding laryngeal
β βββ 64617 Chemodenervation; larynx, for spasmodic dysphonia
β
βββ 64642 Chemodenervation, 1 extremity; 1-4 muscle(s) (Global: 000)
βββ +64643 Chemodenervation, each additional extremity; 1-4 muscle(s) [Add-on]
β
βββ 64644 Chemodenervation, 1 extremity; 5 or more muscle(s) β PRIMARY PARENT (Global: 000)
βββ βΆβΆ +64645 ββ Chemodenervation, each additional extremity; 5 or more muscle(s) β YOU ARE HERE
β βββ [Add-on to 64644 or 64642 | Max 3 units per session | No modifier -51]
β
βββ 64646 Chemodenervation of trunk muscle(s); 1-5 muscle(s) (separate anatomic domain)
βββ +64647 Chemodenervation of trunk muscle(s); 6 or more muscle(s) [Add-on]
π° RVU & Reimbursement Profile
| Component | Value |
|---|---|
| Work RVU (wRVU) | 1.65 (verify against current CMS MPFS for applicable year) |
| Global Period | ZZZ β Add-on Code (global of primary code applies) |
| Add-On Code | β Yes β must be reported with 64644 or 64642 |
| Modifier -51 Exempt | β Yes β add-on codes are exempt by definition |
| Multiple Procedure Reduction | β Does not apply β paid in full alongside primary code |
| Max Units Per Session | 3 (maximum 3 additional extremities beyond the primary) |
| Assistant Surgeon | β Not payable |
| PC/TC Split | β No β procedure code only (Indicator 0) |
Maximum Session wRVU β Full Quad Extremity, All 5+ Muscles
Code Extremity Muscles wRVU 64644 1st (most muscles) 5+ 1.77 64645 Γ 1 2nd extremity 5+ 1.65 64645 Γ 2 3rd extremity 5+ 1.65 64645 Γ 3 4th extremity 5+ 1.65 95874 Γ up to 4 EMG guidance per extremity varies Total procedure wRVU 6.72 Drug J-codes are billed separately and represent additional reimbursement on top of this procedure wRVU stack.
π·οΈ Modifier Reference
| Modifier | Name | When to Apply |
|---|---|---|
| -RT | Right Side | Identifies the additional extremity as right-sided; not required for payment but strongly recommended for documentation clarity and audit defense |
| -LT | Left Side | Identifies left-sided additional extremity |
| -59 | Distinct Procedural Service | Rarely needed; only when a payer incorrectly attempts to bundle 64645 with the primary or another add-on; documents distinct anatomic site |
| β NEVER use -51 on 64645 β add-on codes are exempt from modifier -51; applying it incorrectly may reduce payment | ||
| β Not applicable β bilateral extremity involvement is captured by stacking add-on units, not by modifier -50 |
π©Ί Common ICD-10-CM Pairings
Note
Multi-Extremity 5+ Muscle Spasticity β Highest-Yield Pairings
| ICD-10 Code | Description | HCC? | HCC Category (v28) | Clinical Notes |
|---|---|---|---|---|
| G80.0 | Spastic quadriplegic cerebral palsy | β Yes | HCC Motor/Cognitive | Most common driver of maximum add-on utilization (64644 + 64645 Γ 3); diffuse 5+ muscle involvement per limb is the norm in quad CP |
| G82.50 | Quadriplegia, unspecified | β Yes | HCC Motor/Cognitive | High-level SCI; all four extremities potentially requiring 5+ muscle injection each |
| G82.54 | Quadriplegia, C5-C7, incomplete | β Yes | HCC Motor/Cognitive | Specific SCI level with significant upper and lower extremity spasticity |
| G82.20 | Paraplegia, unspecified | β Yes | HCC Motor/Cognitive | Bilateral lower extremity 5+ muscles each; 64644 + 64645 Γ 1 |
| G80.1 | Spastic diplegic cerebral palsy | β Yes | HCC Motor/Cognitive | Bilateral lower limb with multi-muscle involvement per extremity |
| G35.- | Multiple sclerosis | β Yes | HCC Demyelinating | Progressive multi-limb spasticity; document SPMS vs. RRMS when specified |
| G81.10 | Spastic hemiplegia affecting unspecified side | β Yes | HCC Motor/Cognitive | Ipsilateral upper + lower extremity with 5+ muscles each; 64644 + 64645 Γ 1 |
| I69.351 | Hemiplegia following cerebral infarction, right dominant side | β Yes | Stroke Sequelae HCC | Most specific post-stroke code; preferred when infarction etiology and side clearly documented |
| I69.352 | Hemiplegia following cerebral infarction, left dominant side | β Yes | Stroke Sequelae HCC | Left-sided post-stroke sequela |
CMS LCD Coverage β Spasm of Muscle
| ICD-10 Range | Description | HCC? | Clinical Notes |
|---|---|---|---|
| M62.411-M62.838 | Spasm of muscle, various anatomic sites | β No | Per CMS Article A57185 (Group 8), this range supports medical necessity for 64642-64647 including 64645 when treating spasticity secondary to spastic hemiplegia and hemiparesis; use the most specific anatomic site code available |
HCC Capture Opportunity
Several diagnoses pairing with 64644/64645 carry significant HCC weight under CMS-HCC Model v28. For Medicare Advantage patients, each encounter where these codes are billed is a documentation and RAF-capture opportunity. Conditions such as hemiplegia (G81.xx), quadriplegia (G82.5x), and stroke sequelae (I69.3xx) require current-encounter documentation β historical record alone does not satisfy RAF capture requirements. The treating physicianβs note for the chemodenervation session should reflect the active neurological diagnosis driving the spasticity.
π₯ MS-DRG Considerations (Inpatient)
Inpatient Coding Reminder
CPT 64645 is not used in the inpatient facility setting β ICD-10-PCS governs inpatient procedure coding. As an add-on code with a ZZZ global period, 64645 has no independent MS-DRG mapping. In the inpatient setting, botulinum toxin injection into extremity muscles is captured by PCS code 3E0M3GC β typically assigned once per session regardless of how many extremities or muscles are treated, though facility policy may vary. The DRG is driven entirely by the principal diagnosis and CC/MCC capture.
π§ ICD-10-PCS Equivalents (Inpatient Facility Coding)
| PCS Code | Full Description | Notes |
|---|---|---|
3E0M3GC | Introduction of Other Therapeutic Substance into Muscle, Percutaneous Approach | Applies regardless of muscle count per extremity; body part βMβ (Muscle) encompasses all extremity musculature without distinguishing 1-4 vs. 5+ threshold |
PCS Character Analysis β 3E0M3GC
| Position | Character | Value | Definition |
|---|---|---|---|
| 1 | Section | 3 | Administration |
| 2 | Body System | E | Physiological Systems and Anatomical Regions |
| 3 | Root Operation | 0 | Introduction (putting in or on a therapeutic substance) |
| 4 | Body Part | M | Muscle |
| 5 | Approach | 3 | Percutaneous |
| 6 | Substance | G | Other Therapeutic Substance |
| 7 | Qualifier | C | Other Substance |
PCS and the 5-Muscle Threshold
The CPT distinction between 64644 (5+ muscles) and 64642 (1-4 muscles) has no parallel in ICD-10-PCS. PCS codes by body part and approach β muscle count is not a character in the PCS table. The same 3E0M3GC code applies regardless of whether 3 or 10 muscles were injected in the additional extremity. The CPT hierarchy (which exists to drive appropriate physician reimbursement tiers) does not translate into PCS code selection.
π Coding Examples
Example 1 β Office: Bilateral Lower Extremity, 5+ Muscles Each, Spastic Quadriplegia
Clinical Scenario: A 22-year-old male with spastic quadriplegic cerebral palsy presents for bilateral lower extremity injections. Right lower extremity: gastrocnemius medial, gastrocnemius lateral, soleus, tibialis posterior, flexor digitorum longus β 5 muscles, 250 total units. Left lower extremity: gastrocnemius medial, gastrocnemius lateral, soleus, tibialis posterior, flexor digitorum longus, flexor hallucis longus β 6 muscles, 300 total units. EMG guidance bilaterally.
| Field | Code | Rationale |
|---|---|---|
| CPT 1 | 64644-LT | Primary/base code β left lower extremity has most muscles (6); 5 or more threshold met |
| CPT 2 | 64645-RT | Add-on β right lower extremity; 5 muscles (5 or more threshold); no modifier -51 |
| CPT 3 | 95874 | Needle EMG guidance; one unit β confirm per-extremity vs. per-session billing with your MAC |
| Drug | J0585 Γ 550 | OnabotulinumtoxinA; 250u right + 300u left = 550 total units documented and billed |
| PDx | G80.0 | Spastic quadriplegic cerebral palsy |
Note
The primary code is assigned to the left lower extremity because it has 6 muscles β more than the right lowerβs 5. This follows CPT guidance that the base code represent the limb with the most muscles injected. If the coder had assigned 64644 to the right (treated first procedurally but fewer muscles), the code assignment would be technically incorrect.
Example 2 β Office: Four-Extremity Session, All 5+ Muscles, High SCI
Clinical Scenario: A 34-year-old female with C4 complete quadriplegia and severe bilateral upper and lower limb spasticity presents for quarterly injections. All four extremities receive 5+ muscle injections: right upper (5 muscles), left upper (6 muscles), right lower (7 muscles), left lower (5 muscles). Ultrasound guidance is used for all four extremities.
| Field | Code | Rationale |
|---|---|---|
| CPT 1 | 64644-RT | Primary β right lower extremity; 7 muscles (most muscles of session); primary assigned to most extensively treated limb |
| CPT 2 | 64645-LT | Add-on β left upper extremity; 6 muscles; first add-on unit |
| CPT 3 | 64645-RT | Add-on β right upper extremity; 5 muscles; second add-on unit |
| CPT 4 | 64645-LT | Add-on β left lower extremity; 5 muscles; third add-on unit (maximum) |
| CPT 5 | 76942 | Ultrasound guidance; one unit per session; verify MAC policy on units for bilateral sessions |
| PDx | G82.50 | Quadriplegia, unspecified |
Warning
Three units of 64645 is the absolute maximum per session β anatomically bounded by three additional extremities beyond the primary. A fourth unit of 64645 will deny on MUE. Never append modifier -51 to any unit of 64645 β add-on codes are categorically exempt from the multiple procedure reduction.
Example 3 β Office: Mixed Add-On Session (Some 5+ Muscles, Some 1-4), Post-Stroke Hemiplegia Plus Contralateral Lower Limb
Clinical Scenario: A 63-year-old male with bilateral stroke sequelae presents for a three-extremity session. Right upper extremity: biceps, brachialis, pronator teres, flexor carpi radialis, flexor digitorum superficialis, flexor pollicis longus β 6 muscles. Left upper extremity: biceps, flexor carpi radialis β 2 muscles. Right lower extremity: gastrocnemius medial, gastrocnemius lateral, soleus, tibialis posterior, flexor digitorum longus β 5 muscles.
| Field | Code | Rationale |
|---|---|---|
| CPT 1 | 64644-RT | Primary β right upper extremity; 6 muscles (most in session); 5 or more threshold |
| CPT 2 | 64645-RT | Add-on β right lower extremity; 5 muscles; 5 or more threshold; 64645 for this limb |
| CPT 3 | 64643-LT | Add-on β left upper extremity; 2 muscles; 1-4 threshold; 64643 (not 64645) for this limb |
| PDx | I69.351 | Hemiplegia/hemiparesis following cerebral infarction, right dominant side |
| SDx | I69.352 | Hemiplegia/hemiparesis following cerebral infarction, left dominant side |
Mixed Add-On Combination
This example demonstrates a critical real-world scenario: 64645 and 64643 used together in the same session for different additional extremities, each determined by its own independent muscle count. There is no rule prohibiting the use of both 64645 and 64643 add-ons in the same session β the coder simply evaluates each additional limbβs muscle count independently and assigns the appropriate add-on for each.
β οΈ Common Coding Pitfalls
-
Billing 64645 as a standalone code: 64645 will be denied on any claim that does not include 64644 or 64642 as the primary procedure code. If the primary code is retracted for any reason, 64645 must be simultaneously adjusted off the claim β there is no modifier that allows an add-on to stand alone.
-
Using modifier -51 on 64645: Add-on codes are categorically exempt from modifier -51. Applying -51 results in an inappropriate multiple procedure payment reduction. This is a frequent billing team error when staff unfamiliar with add-on code rules process chemodenervation claims.
-
Exceeding the MUE of 3 units per session: There are four extremities. The primary code accounts for one. The maximum number of add-on units β combined 64643 and 64645 β is three. Billing a fourth add-on unit for any reason will generate an MUE denial.
-
Applying 64645 to an additional extremity with only 1-4 muscles: When an additional extremity has fewer than 5 muscles injected, 64643 is the correct add-on β not 64645. The muscle count of each additional extremity must be evaluated independently.
-
Confusing which limb is the primary: The primary code (64644) must represent the extremity with the most muscles injected. If the primary is assigned to the wrong limb, the add-on selection may cascade incorrectly across the entire claim. Always sort extremity muscle counts before assigning codes.
-
Omitting the drug J-code: The botulinum toxin (J0585-J0588) is always billed separately from procedure codes. Omitting the J-code in a 5+ muscle per limb session leaves a substantial revenue gap β the drug reimbursement frequently exceeds the procedure code reimbursement in high-dose quad-extremity sessions.
-
Not linking diagnoses to all procedure lines: Many clearinghouses and payer adjudication systems require diagnosis pointers on each claim line. Failing to link the relevant ICD-10-CM codes to 64645 lines β not just to the primary 64644 line β can cause the add-on lines to deny for missing medical necessity linkage even when the diagnosis is on the claim.
π Sources
AMA CPT 2025 Professional Edition Β· CMS 2025 Medicare Physician Fee Schedule Final Rule (CMS-1807-F) Β· CMS RVU25A Relative Value Files Β· CMS Billing and Coding Article A57185 β Botulinum Toxin Injections (updated March 2026, Noridian) Β· CMS Billing and Coding Article A52848 β Botulinum Toxins Β· NCCI Policy Manual Chapter 11 (Nervous System), CMS 2024-2025 Β· ICD-10-CM Official Guidelines for Coding and Reporting FY2025 Β· ICD-10-PCS Official Guidelines for Coding and Reporting FY2025 Β· Practical Neurology β Botulinum Toxin Billing & Coding Update (April 2026) Β· Ambu USA β Myoguide CPT Coding Reference Β· Frontiers in Neurology β Botulinum Toxin Utilization, Treatment Patterns, and Healthcare Resource Use (PMC10427537, supplementary data) Β· AAPC Neurology/PM&R Coding Reference 2025 Β· NIH VSAC CPT Code Browser β Code 64645
Crystal's MCW Coder Hub